People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Software / Tech, Other Health Care, Other Technology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Virtuous Software, Inc. | — | Software / Tech | Series C | $149.9M | $831.1M | 2021 |
| Apervita, Inc. | — | Other Health Care | Series B | $68.0M | $499.7M | 2019 |
| Redseal, Inc. | — | Other Technology | Series A | $45.6M | $27.0M | 2017 |
| rMark Bio, Inc. | — | Biotech / Pharma | Seed | $4.5M | $114.1M | 2019 |
Mark Achler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Achler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Smith | 1 | 14 |
| James Douglass | 1 | 10 |
| Nick Sturiale | 1 | 10 |
| Ray Rothrock | 1 | 10 |
| Troy Henikoff | 1 | 9 |
| Michael Liang | 1 | 9 |
| Dino Vendetti | 1 | 7 |
| Adam Koopersmith | 1 | 7 |
| Joseph Horowitz | 1 | 7 |
| Kevin Mosher | 1 | 6 |
| James Bradley | 1 | 6 |
| Pete Sinclair | 1 | 5 |
| Steve Goldberg | 1 | 4 |
| Kevin Hutchinson | 1 | 4 |
| Paul Magelli | 1 | 4 |
| Ben Weinberg | 1 | 4 |
| Mark Ashida | 1 | 4 |
| Bill Funcannon | 1 | 3 |
| Tench Coxe | 1 | 3 |
| Sarah London | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.